GC Biopharma (006280.KR) — market event timeline

NashNova tracks 11 market events mentioning GC Biopharma (006280.KR) between 2026-06-22 and 2026-07-07, each with a dated one-line analysis of how the event relates to the asset.

  1. Fed Minutes Due Today as Warsh's Opaque Style Puts Markets on Alert

    Rate hike expectations weigh on gold prices, but Middle East conflict provides safe-haven support, intensifying the bull-bear tug of war.

  2. HKEX USD Gold Futures Trading Hits Record High as Exchange Waives Fees for One Year

    HKEX USD gold futures are linked to COMEX gold futures; improved liquidity during Asian trading hours influences global gold price discovery.

  3. CMB Macro: June NFP Weakness Hits the Sweet Spot, Market Still Pricing in One Rate Hike This Year

    Soft NFP data weakened rate hike expectations; a weaker dollar directly drove gold prices to rebound near the $4,200 level.

  4. Trump Responds to Warsh Rate Cut: It's His Own Decision

    Swinging rate cut expectations affect real interest rate outlooks; as a zero-yield asset, gold is highly sensitive to the Fed's policy path.

  5. U.S. Initial Jobless Claims Drop to 215K, Labor Market Continues to Show Resilience

    Cooling rate cut expectations push real interest rates higher, increasing the opportunity cost pressure on gold as a zero-yield asset.

  6. BofA: Gold Bull Run Takes a Breather, but Long-Term Bullish Case Remains Intact

    The primary benchmark for BofA's core view on gold price trajectory. The tug-of-war between the Fed's hawkish shift and central bank gold purchases is directly reflected in gold futures pricing.

  7. Goldman Sachs: Copper and Gold Take Over as Commodity Allocation Theme After Hormuz Trade Fades

    Goldman Sachs forecasts gold prices reaching $4,900 by end of 2026, with the structural trend of central bank gold purchases unchanged and 45% of central banks planning to increase holdings.

  8. June Non-Farm Payrolls to Be Released Early Next Thursday; Investec Forecasts 160,000 New Jobs

    Non-farm payrolls influence real interest rates and the U.S. dollar, both core pricing factors for gold; stronger data would be bearish for gold.

  9. U.S. Initial Jobless Claims Drop to 215K, Beating Expectations with a 12K Decline

    Retreating rate cut expectations push up real interest rates and the U.S. dollar, pressuring non-yielding assets like gold.

  10. Fed's Hawkish Pivot Prompts Wall Street Firms to Cut Gold Price Targets

    The Fed's hawkish pivot has fueled rate hike expectations, with rising real interest rates directly undermining the holding value of non-yielding gold.

  11. Morgan Stanley: Lack of ETF Inflows Puts Pressure on $5,200 Gold Price Target

    The article directly references Comex gold prices. Lack of ETF demand and a hawkish Fed path are weighing on futures pricing.

For research and information only — not investment advice.

GC Biopharma (006280.KR) — News & AI Analysis · NashNova